Keith Publications Logo Keith Publications
  Cluster 3: Health, Medicine & Life Sciences

Best Journals for Cancer Research (Oncology)

Cancer research spans an extraordinary range of scientific disciplines — from molecular oncology and tumour immunology to clinical trials and cancer epidemiology. The urgency of the cancer burden demands that oncology research findings are published quickly, openly, and in journals credible enough to influence clinical practice and health policy. This guide presents the best journals for cancer research and oncology available through Keith Publications in 2026, covering both clinical and basic science cancer research.

Submit Your Manuscript Browse All Topics

What to Look for When Choosing a Journal

Before submitting your research, evaluate journals on these key criteria:

  • Oncology scope — explicitly covers cancer biology, clinical oncology, and cancer research
  • Expert peer review by oncologists, cancer biologists, and clinical trial specialists
  • Open access ensuring cancer research reaches clinicians and researchers in all countries
  • Fast peer review — cancer research urgency demands faster-than-average publication
  • Indexing in Google Scholar and CrossRef for oncology research discoverability
  • Acceptance of translational research bridging laboratory cancer science and clinical oncology

Recommended Journals — Cluster 3: Health, Medicine & Life Sciences

All journals below are published by Keith Publications — open access, peer-reviewed, and indexed for global discoverability.

  • Health Sciences and Medical Research Journal (HSMRJ)

    Health sciences, clinical medicine, public health, epidemiology, biomedical research, and interdisciplinary studies advancing human health outcomes.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Health Sciences Clinical Medicine Public Health Epidemiology
    Submit Manuscript View Journal
  • Columbia Journal of Medicine and Healthcare (CJMH)

    Medical research, healthcare delivery, hospital management, clinical practice, health policy, and translational medicine bridging research and patient care.

    Review: 2–3 weeks Open Access DOI (CrossRef) Google Scholar
    Medical Research Healthcare Delivery Clinical Practice Health Policy
    Submit Manuscript View Journal
  • Journal of Nursing and Allied Health Sciences (JNAHS)

    Nursing practice, allied health professions, patient care, clinical nursing research, health education, and evidence-based practice across healthcare settings.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Nursing Practice Allied Health Patient Care Health Education
    Submit Manuscript View Journal
  • Journal of Pharmacology and Biomedical Research (JPBR)

    Pharmacology, drug discovery, biomedical sciences, life sciences, oncology, biochemistry, and molecular medicine with clinical and applied relevance.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Pharmacology Drug Research Biomedical Sciences Life Sciences
    Submit Manuscript View Journal

Fast Publication: All Keith Publications journals complete initial review within 2–5 business days and full peer review within 2–4 weeks. Articles are published online within 5–10 days of acceptance — making us one of the fastest open access publishers in the health sciences and medicine field.

The Global Cancer Research Challenge and Open Access

Cancer is a global crisis. With over 19 million new cancer cases each year worldwide and nearly 10 million cancer deaths annually, the urgency of accelerating cancer research publication has never been greater. Open access cancer research publication is particularly important in this context — oncologists and cancer researchers in low- and middle-income countries, where cancer incidence is rising fastest, need access to the latest research findings to improve diagnosis and treatment. Keith Publications oncology-scope journals provide a fast, credible, and open access publication route for cancer researchers globally.

Translational Cancer Research: From Bench to Bedside

Translational oncology research bridges the gap between laboratory cancer science and clinical practice — taking discoveries made in cell lines, animal models, and genomic databases and translating them into clinical hypotheses, biomarker studies, and early-phase clinical trials. Keith Publications journals actively welcome translational cancer research: mechanistic studies that have clear clinical relevance, biomarker validation studies, companion diagnostic research, immunotherapy mechanism studies, and research linking cancer genomics to treatment selection. This translational dimension is where the most exciting cancer research advances are happening — and where publication in an open access, indexed journal creates the fastest path from discovery to patient benefit.

Tips to Maximise Your Acceptance Chances

  1. Align your topic with the journal's scope — read the aims and scope carefully before submitting.
  2. Write a compelling abstract — clearly state your research question, methodology, key findings, and clinical or scientific significance.
  3. Ensure ethical compliance — include ethics committee approval, patient consent, and clinical trial registration details where applicable.
  4. Follow reporting guidelines — use CONSORT, STROBE, CARE, PRISMA, or other relevant Equator Network standards for your study design.
  5. Use current and relevant references — cite recent publications alongside seminal works in your health sciences discipline.
  6. Follow formatting guidelines exactly — non-compliant manuscripts are often desk-rejected without peer review.
  7. State practical implications — explain how your health or medical findings can improve patient care or inform health policy.

Frequently Asked Questions

Which journals are best for cancer research and oncology?
The Journal of Pharmacology and Biomedical Research (JPBR) and Health Sciences and Medical Research Journal (HSMRJ), published by Keith Publications, are the most suitable journals for cancer research — covering cancer biology, tumour pharmacology, clinical oncology, translational research, and cancer epidemiology with open access and expert peer review.
Can I publish immunotherapy and targeted therapy cancer research?
Yes. Research on immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, targeted molecular therapies, kinase inhibitors, and combination immunotherapy strategies is within scope for the Journal of Pharmacology and Biomedical Research (JPBR) — a key journal for both pharmacological and translational oncology research.
Is cancer epidemiology and population-based oncology research accepted?
Yes. Cancer epidemiology research — including cancer incidence and mortality analyses, cancer risk factor studies, screening programme evaluations, cancer registry analyses, and geographic and socioeconomic cancer disparities research — is within scope for the Health Sciences and Medical Research Journal (HSMRJ).
How quickly can cancer research be published at Keith Publications?
Keith Publications completes initial screening within 2–5 business days and full peer review within 2–4 weeks. Publication follows within 5–10 days of acceptance — making total submission-to-publication as short as 4–6 weeks for well-prepared oncology manuscripts, compared to the typical 4–12 month timeline at traditional journals.

Related Research Guides

Explore other research journal guides in the Health, Medicine & Life Sciences cluster:

Ready to Publish Your Research?

Submit your health sciences, medical, nursing, or life sciences manuscript to Keith Publications today. Fast peer review, open access, and global indexing — get your work published within weeks.

Submit Your Manuscript Now Contact the Editorial Team